Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potassium and ventricular arrhythmias.

P J Podrid1

  • 1Evans Memorial Research Division, Boston University School of Medicine, Massachusetts.

The American Journal of Cardiology
|March 6, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventricular Tachycardia in the Young Athlete: A Systematic Approach to Selection of Drug Therapy.

The Physician and sportsmedicine·2016
Same author

Proarrhythmia, a serious complication of antiarrhythmic drugs.

Current cardiology reports·2000
Same author

Prevention of postoperative atrial fibrillation: what is the best approach?

Journal of the American College of Cardiology·1999
Same author

Redefining the role of antiarrhythmic drugs.

The New England journal of medicine·1999
Same author

Atrial fibrillation in the elderly.

Cardiology clinics·1999
Same author

Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial.

Annals of internal medicine·1998
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Hypokalemia (low potassium) is linked to ventricular arrhythmias, especially during ischemia. It may also reduce the effectiveness of antiarrhythmic drugs, impacting cardiac electrical stability.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • Potassium significantly influences myocardial membrane electrophysiology and arrhythmia development.
  • The association between hypokalemia and ventricular premature complexes (VPCs) is debated, with conflicting evidence in hypertensive and post-myocardial infarction patients.

Purpose of the Study:

  • To clarify the role of hypokalemia in cardiac arrhythmias, particularly ventricular tachycardia and fibrillation during ischemia.
  • To investigate the impact of hypokalemia on antiarrhythmic drug efficacy.
  • To explore mechanisms linking hypokalemia to sudden cardiac death prevention by beta-blockers.

Main Methods:

  • Review of existing animal and clinical studies.
  • Analysis of the electrophysiologic effects of potassium on the myocardium.

Related Experiment Videos

  • Examination of the interplay between hypokalemia, ischemia, and cardiac electrical instability.

    • Main Results:

    • Hypokalemia is strongly associated with sustained ventricular tachycardia and ventricular fibrillation during acute ischemic events.
    • The link between hypokalemia and simple VPCs remains uncertain.
    • Hypokalemia can alter myocardial electrophysiology, potentially diminishing the effectiveness of antiarrhythmic medications.
    • Epinephrine-induced hypokalemia via beta-2 adrenoreceptor stimulation may contribute to the cardioprotective effects of beta-blockers post-myocardial infarction.

    Conclusions:

    • Hypokalemia is a critical factor in the genesis of life-threatening ventricular arrhythmias during ischemia.
    • Management of potassium levels is crucial for effective antiarrhythmic therapy and preventing sudden cardiac death.
    • Understanding hypokalemia's mechanisms offers insights into cardiovascular drug actions and patient outcomes.